Cargando…

Long‐term outcomes of cardiac resynchronization therapy in adult congenital heart disease

BACKGROUND AND AIMS: Randomized, controlled trials of cardiac resynchronization therapy (CRT) excluded patients with adult congenital heart disease (ACHD). We sought to explore long‐term clinical outcomes. METHODS AND RESULTS: In this single‐center, observational study, events were collected from ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leyva, Francisco, Zegard, Abbasin, Qiu, Tian, de Bono, Joseph, Thorne, Sara, Clift, Paul, Marshall, Howard, Hudsmith, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Devices
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850101/ https://www.ncbi.nlm.nih.gov/pubmed/30908673 http://dx.doi.org/10.1111/pace.13670

Ejemplares similares

Renal function and the long‐term clinical outcomes of cardiac resynchronization therapy with or without defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Timing of cardiac resynchronization therapy implantation
por: Leyva, Francisco, et al.
Publicado: (2023)

Improved prognosis after cardiac resynchronization therapy over a decade
por: Leyva, Francisco, et al.
Publicado: (2023)

Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias
por: Okafor, Osita, et al.
Publicado: (2019)

Survival after cardiac resynchronization therapy: results from 50 084 implantations
por: Leyva, Francisco, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy Using Quadripolar Versus Non‐Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single‐Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization
por: Leyva, Francisco, et al.
Publicado: (2017)

Sex‐Specific Differences in Survival and Heart Failure Hospitalization After Cardiac Resynchronization Therapy With or Without Defibrillation
por: Leyva, Francisco, et al.
Publicado: (2019)

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
por: Leyva, Francisco, et al.
Publicado: (2018)

Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35%
por: Zegard, Abbasin, et al.
Publicado: (2021)

Long‐Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing
por: Leyva, Francisco, et al.
Publicado: (2018)

Cardiac resynchronization therapy with intraoperative epicardial mapping via minithoracotomy: 10 years’ experience
por: Hejjel, László, et al.
Publicado: (2020)

Improvement of Right Ventricular Hemodynamics with Left Ventricular Endocardial Pacing during Cardiac Resynchronization Therapy
por: HYDE, EOIN R., et al.
Publicado: (2016)

Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience
por: Kutyifa, Valentina, et al.
Publicado: (2014)

Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective
por: Leyva, Francisco, et al.
Publicado: (2021)

Septal flash correction with His‐Purkinje pacing predicts echocardiographic response in resynchronization therapy
por: Pujol‐López, Margarida, et al.
Publicado: (2022)

Patient‐activated anti‐tachycardia pacing in adult congenital heart disease
por: Carberry, Thomas, et al.
Publicado: (2022)

Device rounds: T-wave oversensing: A cause of loss of cardiac resynchronization therapy
por: Dayal, Nicolas B., et al.
Publicado: (2016)

Long-term clinical outcomes after upgrade to resynchronization therapy: A propensity score–matched analysis
por: Brandão, Mariana, et al.
Publicado: (2021)

The long‐term outcomes of cardiac implantable electronic devices implanted via the femoral route
por: Griffiths, Samuel, et al.
Publicado: (2022)

Cardiac resynchronization therapy with multipoint pacing via quadripolar lead versus traditional biventricular pacing: A systematic review and meta-analysis of clinical studies on hemodynamic, clinical, and prognostic parameters
por: Massacesi, Cristiano, et al.
Publicado: (2021)

Atypical pathogens associated with cardiac implantable electronic device infections
por: Kohli, Utkarsh, et al.
Publicado: (2021)

Novel two‐lead cardiac resynchronization therapy system provides equivalent CRT responses with less complications than a conventional three‐lead system: Results from the QP ExCELs lead registry
por: Shaik, Naushad A., et al.
Publicado: (2020)

Diagnostic yield of a heart failure referral pathway using N-terminal pro-brain natriuretic peptide
por: Zegard, Abbasin, et al.
Publicado: (2023)

Clinical evaluation of a small implantable cardiac monitor with a long sensing vector
por: Piorkowski, Christopher, et al.
Publicado: (2019)

The missing link: Unlocking the power of cardiac rhythm monitoring device based QT interval detection
por: Chu, Antony F., et al.
Publicado: (2022)

iPhone 12 MagSafe technology and cardiac implantable devices: Assessment of the actual risk
por: Censi, Federica, et al.
Publicado: (2022)

Pneumopericardium and Pneumomediastinum After Implantation of a Cardiac Resynchronization Pacemaker
por: Green, Peregrine G., et al.
Publicado: (2019)

Long-Term Follow-Up of Patients with Chronic Chagas Disease and Implantable Cardioverter-Defibrillator
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2014)

Home delivery of the communicator for remote monitoring of cardiac implantable devices: A multicenter experience during the covid‐19 lockdown
por: Magnocavallo, Michele, et al.
Publicado: (2021)

Distinct impacts of heart rate and right atrial‐pacing on left atrial mechanical activation and optimal AV delay in CRT
por: Kyriacou, Andreas, et al.
Publicado: (2018)

Accuracy of arrhythmia detection in implantable cardiac monitors: A prospective randomized clinical trial comparing Reveal LINQ and Confirm Rx
por: Ip, John, et al.
Publicado: (2020)

Long‐term follow‐up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality
por: Mattsson, Gustav, et al.
Publicado: (2020)

R-Wave Sensing in an Implantable Cardiac Monitor without ECG-Based Preimplant Mapping: Results from a Multicenter Clinical Trial
por: Krahn, Andrew D, et al.
Publicado: (2014)

Medium-Term Effects of Septal and Apical Pacing in Pacemaker-Dependent Patients: A Double-Blind Prospective Randomized Study
por: Molina, Luis, et al.
Publicado: (2014)

Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials
por: Coats, Andrew J.S., et al.
Publicado: (2022)

Heart failure treatment in patients with cardiac implantable electronic devices: Opportunity for improvement
por: Salimian, Samaneh, et al.
Publicado: (2021)

Long‐Term Outcome of Patients With Congenital Heart Disease Undergoing Cardiac Resynchronization Therapy
por: Kubuš, Peter, et al.
Publicado: (2021)

Clinical Pathways Guided by Remotely Monitoring Cardiac Device Data: The Future of Device Heart Failure Management?
por: Taylor, Joanne K, et al.
Publicado: (2023)

Cardiac Resynchronization Therapy in a Chagasic Patient With Persistent Left Superior Vena Cava
por: Hollanda, Lucas, et al.
Publicado: (2019)

Cardiac resynchronization therapy guided by cardiovascular magnetic resonance
por: Leyva, Francisco
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2v14et7fiv3ea3q2plvtdeflee